Timothy A. Springer 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-15 4:25 pm Purchase | 2025-01-13 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,555,394 36.900% | 21,178 (+0.22%) | Filing |
| 2024-12-23 8:22 pm Purchase | 2024-12-19 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,534,216 36.800% | 52,400 (+0.55%) | Filing |
| 2024-11-18 9:44 pm Purchase | 2024-11-14 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,481,816 37.100% | 434,128 (+4.80%) | Filing |
| 2024-10-04 6:08 pm Purchase | 2024-10-02 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,047,688 37.600% | 205,932 (+2.33%) | Filing |
| 2024-09-27 4:20 pm Purchase | 2024-09-25 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 8,841,756 36.700% | 8,650 (+0.10%) | Filing |
| 2024-07-05 4:15 pm Purchase | 2024-07-02 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 8,833,106 36.300% | 8,833,106 (New Position) | Filing |